Regeneron Pharmaceuticals (REGN) Gross Profit Growth (1y) (2010 - 2026)
Regeneron Pharmaceuticals (REGN) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 75.94% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 7.76% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 16.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.94% |
| Dec 31, 2025 | 8.21% |
| Sep 30, 2025 | 1.60% |
| Jun 30, 2025 | 2.26% |
| Mar 31, 2025 | -4.12% |
| Dec 31, 2024 | 7.39% |
| Sep 30, 2024 | 9.76% |
| Jun 30, 2024 | 12.87% |
| Mar 31, 2024 | 1.33% |
| Dec 31, 2023 | 2,429.55% |
| Sep 30, 2023 | 14.17% |
| Jun 30, 2023 | 8.77% |
| Mar 31, 2023 | 1,951.88% |
| Dec 31, 2022 | -103.34% |
| Sep 30, 2022 | -14.78% |
| Jun 30, 2022 | -45.67% |
| Mar 31, 2022 | -106.71% |
| Dec 31, 2021 | 73.55% |
| Sep 30, 2021 | 49.72% |
| Jun 30, 2021 | 180.17% |